| |
|
|
| Name: |
TANG CAPITAL MANAGEMENT LLC |
| City: |
SAN DIEGO |
| State: |
CA |
| Zip: |
92121 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
26 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MRTX |
Mirati Therapeutics, Inc. |
1 |
- |
$58.70 |
$91,536,000 |
1,558,059 |
8.46% |
83,695,000 |
1,378,059 |
2.328 |
Biotechnology |
|
|
IMGN |
Immunogen Inc |
2 |
- |
$31.23 |
$65,204,000 |
2,199,137 |
6.02% |
41,399,000 |
699,137 |
0.996 |
Drug Manufacturers - ... |
|
|
TARS |
Tarsus Pharmaceuticals, Inc. |
3 |
- |
$0.00 |
$44,647,000 |
2,204,797 |
4.13% |
6,609,000 |
64,211 |
8.267 |
N/A |
|
|
LIAN |
Lianbio |
5 |
- |
$0.00 |
$41,870,000 |
9,366,783 |
3.87% |
39,188,000 |
7,566,783 |
8.734 |
N/A |
|
|
GRCL |
Gracell Biotechnologies Adr... |
13 |
- |
$0.00 |
$22,002,000 |
2,191,417 |
2.03% |
21,544,000 |
2,032,330 |
3.261 |
N/A |
|
|
AVDL |
AVADEL Pharmaceuticals Plc |
20 |
- |
$15.99 |
$15,243,000 |
1,079,528 |
1.41% |
4,943,000 |
79,528 |
1.854 |
Drug Delivery |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
21 |
- |
$13.81 |
$15,092,000 |
692,925 |
1.39% |
4,828,000 |
23,800 |
1.529 |
N/A |
|
|
CRSP |
Crispr Therapeutics Ag |
22 |
- |
$53.81 |
$13,459,000 |
215,000 |
1.24% |
13,459,000 |
215,000 |
0.304 |
N/A |
|
|
AVIR |
Atea Pharmaceuticals, Inc. |
24 |
- |
$0.00 |
$12,434,000 |
4,076,741 |
1.15% |
1,634,000 |
476,741 |
4.934 |
N/A |
|
|
CTMX |
Cytomx Therapeutics, Inc. |
29 |
- |
$0.00 |
$10,153,000 |
6,550,000 |
0.94% |
1,832,000 |
100,000 |
10.052 |
N/A |
|
|
ASND |
Ascendis Pharma AS |
33 |
- |
$141.01 |
$8,817,000 |
70,000 |
0.81% |
7,881,000 |
60,000 |
0.108 |
N/A |
|
|
CBAY |
Cymabay Therapeutics, Inc. |
35 |
- |
$32.48 |
$8,267,000 |
350,000 |
0.76% |
5,285,000 |
150,000 |
0.369 |
N/A |
|
|
CGEM |
Cullinan Oncology Ord Shs |
37 |
- |
$0.00 |
$7,858,000 |
771,138 |
0.73% |
2,237,000 |
150,000 |
1.772 |
N/A |
|
|
RCKT |
Rocket Pharmaceuticals |
39 |
- |
$22.53 |
$7,493,000 |
250,000 |
0.69% |
4,419,000 |
100,000 |
0.318 |
N/A |
|
|
GRPH |
Graphite Bio, Inc. |
40 |
- |
$0.00 |
$6,528,000 |
2,491,780 |
0.6% |
1,527,000 |
475,154 |
4.29 |
N/A |
|
|
CVBF |
CVB Financial Corp |
45 |
- |
$16.75 |
$6,057,000 |
300,000 |
0.56% |
2,743,000 |
100,000 |
0.221 |
Domestic Regional Banks |
|
|
BDTX |
Black Diamond Therapeutics,... |
55 |
- |
$5.90 |
$5,067,000 |
1,803,200 |
0.47% |
3,919,000 |
1,403,200 |
5.009 |
N/A |
|
|
RAIN |
Rain Therapeutics Inc. |
60 |
- |
$0.00 |
$4,621,000 |
3,850,513 |
0.43% |
1,398,000 |
110,172 |
14.525 |
N/A |
|
|
BOLT |
Bolt Biotherapeutics, Inc. |
64 |
- |
$1.12 |
$4,091,000 |
3,652,244 |
0.38% |
392,000 |
95,204 |
10.05 |
N/A |
|
|
DSGN |
Design Therapeutics, Inc. |
66 |
- |
$0.00 |
$3,924,000 |
1,480,675 |
0.36% |
738,000 |
130,675 |
2.662 |
N/A |
|
|
BOH |
Bank Of Hawaii Corp |
70 |
- |
$58.00 |
$3,623,000 |
50,000 |
0.33% |
2,132,000 |
20,000 |
0.125 |
Domestic Regional Banks |
|
|
ACAD |
Acadia Pharmaceuticals Inc |
71 |
- |
$17.05 |
$3,582,000 |
114,400 |
0.33% |
1,498,000 |
14,400 |
0.071 |
Biotechnology |
|
|
AMLX |
Amylyx Pharmaceuticals, Inc. |
79 |
- |
$0.00 |
$2,944,000 |
200,000 |
0.27% |
2,944,000 |
200,000 |
0.346 |
N/A |
|
|
ATHA |
Athira Pharma, Inc. |
81 |
- |
$0.00 |
$2,801,000 |
1,152,715 |
0.26% |
2,089,000 |
800,000 |
3.74 |
N/A |
|
|
PASG |
Passage Bio, Inc. |
85 |
- |
$1.35 |
$2,424,000 |
2,400,000 |
0.22% |
2,161,000 |
2,000,000 |
5.271 |
N/A |
|
|
NXTC |
Nextcure, Inc. |
114 |
- |
$0.00 |
$533,000 |
467,922 |
0.05% |
17,000 |
67,922 |
1.698 |
N/A |
|
